Loading clinical trials...
Loading clinical trials...
Shanghai General Hospital, Shanghai, Jiao Tong University School of Medicine
Conditions
Interventions
Fludarabine
Locations
1
China
Shanghai General Hospital
Shanghai, China
Start Date
May 15, 2022
Primary Completion Date
November 30, 2023
Completion Date
December 30, 2025
Last Updated
May 18, 2022
NCT07101588
NCT06093867
NCT05534620
NCT07013370
NCT06912347
NCT03719092
Lead Sponsor
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions